OQS
CVS icon

Occudo Quantitative Strategies’s CVS Health CVS Stock Holding History

Occudo Quantitative Strategies’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-14,704
Closed -$987K – 682
2025
Q1 		$987K Buy
14,704
+8,772
+148% +$525K 0.13% 229
2024
Q4 		$266K Sell
5,932
-2,283
-28% -$128K 0.05% 491
2024
Q3 		$517K Buy
+8,215
New +$479K 0.09% 267
2023
Q4 		– Sell
-11,797
Closed -$824K – 866
2023
Q3 		$824K Buy
+11,797
New +$836K 0.11% 328
2022
Q3 		– Sell
-7,464
Closed -$692K – 1226
2022
Q2 		$692K Sell
7,464
-21,672
-74% -$2.12M 0.06% 506
2022
Q1 		$2.95M Buy
29,136
+3,290
+13% +$346K 0.25% 88
2021
Q4 		$2.67M Buy
+25,846
New +$2.39M 0.24% 109
2021
Q3 		– Sell
-14,795
Closed -$1.23M – 1036
2021
Q2 		$1.23M Buy
+14,795
New +$1.21M 0.19% 154

Other funds holding CVS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Occudo Quantitative Strategies's CVS Position: Q2 2025 in Review

Occudo Quantitative Strategies sold out of CVS Health (CVS) in Q2 2025, closing a stake of 14,704 shares — an estimated $987K sold.

Occudo Quantitative Strategies first reported a position in CVS in Q2 2021 and held it in 8 quarters. The position peaked at $2.95M in Q1 2022. 1,757 funds tracked by Wall St. Rank hold CVS as of Q2 2025.

  • Occudo Quantitative Strategies reported no remaining CVS Health position as of Q2 2025 after selling out during the quarter.
  • Occudo Quantitative Strategies sold 14,704 CVS Health shares in Q2 2025, an estimated $987K.
  • Occudo Quantitative Strategies first reported a position in CVS Health in Q2 2021 and held it in 8 quarters.
  • Occudo Quantitative Strategies's CVS Health position peaked at $2.95M in Q1 2022.
  • 1,757 funds tracked by Wall St. Rank held CVS Health as of Q2 2025.

Based on Occudo Quantitative Strategies's 13F filing for Q2 2025, filed 14 Aug 2025.